T. Rowe Price Associates’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,314
| Closed | -$66K | – | 3074 |
|
|
2022
Q2 | $66K | Buy |
1,314
+557
| +74% | +$28K | ﹤0.01% | 2820 |
|
|
2022
Q1 | $107K | Buy |
757
+171
| +29% | +$24.2K | ﹤0.01% | 2825 |
|
|
2021
Q4 | $100K | Buy |
586
+155
| +36% | +$26.5K | ﹤0.01% | 2872 |
|
|
2021
Q3 | $215K | Buy |
431
+2
| +0.5% | +$998 | ﹤0.01% | 2691 |
|
|
2021
Q2 | $215K | Buy |
429
+52
| +14% | +$26.1K | ﹤0.01% | 2696 |
|
|
2021
Q1 | $191K | Sell |
377
-150
| -28% | -$76K | ﹤0.01% | 2695 |
|
|
2020
Q4 | $252K | Hold |
527
| – | – | ﹤0.01% | 2487 |
|
|
2020
Q3 | $151K | Buy |
527
+150
| +40% | +$43K | ﹤0.01% | 2468 |
|
|
2020
Q2 | $72K | Hold |
377
| – | – | ﹤0.01% | 2443 |
|
|
2020
Q1 | $47K | Hold |
377
| – | – | ﹤0.01% | 2459 |
|
|
2019
Q4 | $66K | Hold |
377
| – | – | ﹤0.01% | 2476 |
|
|
2019
Q3 | $57K | Hold |
377
| – | – | ﹤0.01% | 2473 |
|
|
2019
Q2 | $44K | Sell |
377
-5
| -1% | -$584 | ﹤0.01% | 2512 |
|
|
2019
Q1 | $64K | Hold |
382
| – | – | ﹤0.01% | 2484 |
|
|
2018
Q4 | $45K | Buy |
382
+1
| +0.3% | +$118 | ﹤0.01% | 2512 |
|
|
2018
Q3 | $58K | Buy |
381
+74
| +24% | +$11.3K | ﹤0.01% | 2548 |
|
|
2018
Q2 | $203K | Buy |
307
+92
| +43% | +$60.8K | ﹤0.01% | 2447 |
|
|
2018
Q1 | $220K | Buy |
+215
| New | +$220K | ﹤0.01% | 2373 |
|